Literature DB >> 9288086

Heterozygote advantage for HLA class-II type in hepatitis B virus infection.

M R Thursz, H C Thomas, B M Greenwood, A V Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9288086     DOI： 10.1038/ng0997-11

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  68 in total

1.  Major histocompatibility complex variation in the endangered Przewalski's horse.

Authors:  P W Hedrick; K M Parker; E L Miller; P S Miller
Journal:  Genetics       Date:  1999-08       Impact factor: 4.562

Review 2.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

3.  Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure?

Authors:  R Hermann; M Knip; R Veijola; O Simell; A-P Laine; H K Akerblom; P-H Groop; C Forsblom; K Pettersson-Fernholm; J Ilonen
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

4.  Major histocompatibility complex controls the trajectory but not host-specific adaptation during virulence evolution of the pathogenic fungus Cryptococcus neoformans.

Authors:  Erin E McClelland; Frederick R Adler; Donald L Granger; Wayne K Potts
Journal:  Proc Biol Sci       Date:  2004-08-07       Impact factor: 5.349

5.  High MHC diversity maintained by balancing selection in an otherwise genetically monomorphic mammal.

Authors:  Andres Aguilar; Gary Roemer; Sally Debenham; Matthew Binns; David Garcelon; Robert K Wayne
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

6.  HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.

Authors:  Heather A Prentice; Philip K Ehrenberg; Karen M Baldwin; Aviva Geretz; Charla Andrews; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; Robert J O'Connell; Merlin L Robb; Jerome H Kim; Nelson L Michael; Rasmi Thomas
Journal:  Immunogenetics       Date:  2014-03-29       Impact factor: 2.846

7.  The course of malaria in mice: major histocompatibility complex (MHC) effects, but no general MHC heterozygote advantage in single-strain infections.

Authors:  Claus Wedekind; Mirjam Walker; Tom J Little
Journal:  Genetics       Date:  2005-05-23       Impact factor: 4.562

8.  HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

Authors:  T-W Wu; C-C Chu; H-W Chang Liao; S-K Lin; T-Y Ho; M Lin; H H Lin; L-Y Wang
Journal:  Genes Immun       Date:  2013-11-28       Impact factor: 2.676

9.  Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.

Authors:  Chloe L Thio; Jacquie Astemborski; Arman Bashirova; Timothy Mosbruger; Spencer Greer; Mallory D Witt; James J Goedert; Margaret Hilgartner; Audrey Majeske; Stephen J O'Brien; David L Thomas; Mary Carrington
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  MHC heterozygosity confers a selective advantage against multiple-strain infections.

Authors:  Dustin J Penn; Kristy Damjanovich; Wayne K Potts
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.